Two Reasons Osimertinib in 1st Line Good Toxicity Profile & Crossing Blood Brain Barrier - 102262

Spotlight
Video

Two Reasons Osimertinib in 1st Line Good Toxicity Profile & Crossing Blood Brain Barrier

Loading........
Description: Anne S. Tsao, MD of MD Anderson Cancer Center discusses two reasons Osimertinib is good for first line treatment such as it's good toxicity profile and how it crosses the blood brain barrier from the 22nd Annual Perspectives in Thoracic Oncology in New York http://imedex.com/perspecti...
Shared By : thoraciconcology
Posted on : 12/29/17
Added : 22 days ago



Recommended

Nothing found.

More From thoraciconcology

Nothing found.